Home / CELU : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CELU make money? Does CELU have pricing power? What's the Earnings Whisper? Will CELU profit more as the business scales? What is CELU's management track record? Is CELU's current price justified?

Celularity Inc.

$1.4 +$0.19 (+15.70%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$1.41

Day Range

$1.32$1.43

Year Range

$0.56$2.55

Market Cap

40.52M

AVG Volume

134.75K

Trailing/Forward PE

-0.38/0.93

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

NASDAQ

Revenue (USD) · TTM

CELU Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
25 Q4	26.55M
25 Q3	40.58M
25 Q2	44.59M
25 Q1	50.97M
24 Q4	54.22M
24 Q3	48.2M
24 Q2	42.69M
24 Q1	33.52M
23 Q4	22.77M
23 Q3	14.79M

Net Income (USD) · TTM

CELU Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
25 Q4	-91.71M
25 Q3	-80.64M
25 Q2	-73.67M
25 Q1	-55.63M
24 Q4	-57.89M
24 Q3	-35.05M
24 Q2	-112.83M
24 Q1	-154.29M
23 Q4	-196.29M
23 Q3	-181.41M

Operating Income (USD) · TTM

CELU Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
25 Q4	-61.31M
25 Q3	-48.53M
25 Q2	-47.16M
25 Q1	-41.47M
24 Q4	-38.36M
24 Q3	-15.76M
24 Q2	-103.49M
24 Q1	-135.79M
23 Q4	-192.29M
23 Q3	-188.12M

EBITDA (USD) · TTM

CELU EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
25 Q4	-77.62M
25 Q3	-63.56M
25 Q2	-56.28M
25 Q1	-38.47M
24 Q4	-41.7M
24 Q3	-42.65M
24 Q2	-120.76M
24 Q1	-162.34M
23 Q4	-205.01M
23 Q3	-225.76M

Cash Flows (USD) · TTM

CELU Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
25 Q4	-13.25M
25 Q3	-6.61M
25 Q2	-2.63M
25 Q1	-5.11M
24 Q4	-6.56M
24 Q3	-13.02M
24 Q2	-21.39M
24 Q1	-28.97M
23 Q4	-42.73M
23 Q3	-68.18M

EPS (USD) · TTM

CELU EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
25 Q4	-3.69
25 Q3	-3.34
25 Q2	-3.19
25 Q1	-2.46
24 Q4	-2.65
24 Q3	-1.56
24 Q2	-5.82
24 Q1	-8.23
23 Q4	-11.33
23 Q3	-10.18

Expenses (USD) · TTM

CELU Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
25 Q4	66.29M
25 Q3	67.82M
25 Q2	70.52M
25 Q1	74.27M
24 Q4	76.19M
24 Q3	177.97M
24 Q2	177.53M
24 Q1	179.25M
23 Q4	193.43M
23 Q3	102.56M

Shares Outstanding (USD) · TTM

CELU Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
25 Q4	-10.38M
25 Q3	-10.22M
25 Q2	-10.86M
25 Q1	-11.4M
24 Q4	-11.73M
24 Q3	-12.2M
24 Q2	-13.13M
24 Q1	-13.99M
23 Q4	-15.02M
23 Q3	-15.83M

Employee Count

CELU Employee Count by quarter
Period	Employee Count
2025	115
2024	123
2023	120
2022	225
2021	225
2019	4

PE Ratio

CELU PE Ratio by quarter
Period	PE Ratio
Aug 23	3.81
Aug 23	4.31
Jul 23	4.68
Jul 23	6.71
Jul 23	5.93
Jul 23	5.96
Jun 23	6.35
Jun 23	7.98
Jun 23	9.65
Jun 23	7.79
Jun 23	8.42
May 23	7.2
May 23	6.82
May 23	5.29
May 23	5.31
Apr 23	6.2
Apr 23	7.22
Apr 23	7.11
Apr 23	7.21
Mar 23	6.51
Nov 22	10.13
Oct 22	10.63
Oct 22	10.31
Oct 22	9.45
Oct 22	9.54
Sep 22	10.49
Sep 22	11.4
Sep 22	9.63
Sep 22	11.17
Sep 22	12.54
Aug 22	13.08
Aug 22	12.81
Aug 22	13.94

Free Cash Flow Yield

CELU Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-36.98%
Sep 26	-36.72%
Sep 26	-30.82%
Aug 26	-32.77%
Aug 26	-64.72%
Aug 26	-74.41%
Aug 26	-73.89%
Jul 26	-81.5%
Jul 26	-69.04%
Jul 26	-66.35%
Jul 26	-69.93%
Jul 26	-83.55%
Jun 26	-83.51%
Jun 26	-68.82%
Jun 26	-72.63%
Jun 26	-59.36%
May 26	-51.26%
May 26	-59.51%
May 26	-64.06%
May 26	-58.84%
May 26	-54.1%
Apr 26	-22.61%
Apr 26	-20.41%
Apr 26	-19.76%
Apr 26	-18.87%
Mar 26	-20.57%
Mar 26	-20.57%
Mar 26	-20.57%
Mar 26	-20.74%
Feb 26	-20.41%
Feb 26	-18.59%
Feb 26	-19.92%
Feb 26	-19.31%
Jan 26	-20.57%
Jan 26	-19.46%
Jan 26	-19.16%
Jan 26	-19.31%
Jan 26	-20.74%
Dec 25	-18.73%
Dec 25	-17.31%
Dec 25	-15.69%
Dec 25	-12.68%
Nov 25	-12.55%
Nov 25	-14.34%
Nov 25	-16.19%
Nov 25	-6.16%
Oct 25	-5.62%
Oct 25	-5.3%
Oct 25	-5.54%
Oct 25	-5.35%
Oct 25	-5.15%
Sep 25	-4.87%
Sep 25	-4.94%
Sep 25	-4.72%
Sep 25	-4.55%
Aug 25	-2.78%
Aug 25	-7.75%
Aug 25	-8.44%
Aug 25	-9.06%
Aug 25	-9.41%
Jul 25	-9.92%
Jul 25	-9.69%
Jul 25	-13.91%
Jul 25	-14.83%
Jun 25	-15.87%
Jun 25	-16.68%
Jun 25	-16.78%
Jun 25	-14.11%
May 25	-13.91%
May 25	-12.82%
May 25	-14.39%
May 25	-17.58%
May 25	-37.03%
Apr 25	-36.8%
Apr 25	-37.98%
Apr 25	-36.13%
Apr 25	-42.93%
Mar 25	-33.47%
Mar 25	-32.55%
Mar 25	-38.23%
Mar 25	-48.17%
Feb 25	-51.08%
Feb 25	-35.27%
Feb 25	-27.69%
Feb 25	-27.43%
Jan 25	-28.9%
Jan 25	-23.7%
Jan 25	-25.76%
Jan 25	-27.43%
Jan 25	-25.76%
Dec 24	-26.45%
Dec 24	-25.43%
Dec 24	-26.69%
Dec 24	-25.11%
Nov 24	-47.99%
Nov 24	-35.47%
Nov 24	-39.8%
Nov 24	-27.58%
Nov 24	-93.83%
Oct 24	-72.65%

Price to Sales

CELU Price to Sales by quarter
Period	Price to Sales
Sep 26	1.35
Sep 26	1.36
Sep 26	1.62
Aug 26	1.52
Aug 26	0.77
Aug 26	0.67
Aug 26	0.68
Jul 26	0.61
Jul 26	0.72
Jul 26	0.75
Jul 26	0.71
Jul 26	0.6
Jun 26	0.6
Jun 26	0.73
Jun 26	0.69
Jun 26	0.84
May 26	0.97
May 26	0.84
May 26	0.78
May 26	0.85
May 26	0.92
Apr 26	0.72
Apr 26	0.8
Apr 26	0.82
Apr 26	0.86
Mar 26	0.79
Mar 26	0.79
Mar 26	0.79
Mar 26	0.79
Feb 26	0.8
Feb 26	0.88
Feb 26	0.82
Feb 26	0.84
Jan 26	0.79
Jan 26	0.84
Jan 26	0.85
Jan 26	0.84
Jan 26	0.79
Dec 25	0.87
Dec 25	0.94
Dec 25	1.04
Dec 25	1.29
Nov 25	1.3
Nov 25	1.14
Nov 25	1.01
Nov 25	0.96
Oct 25	1.05
Oct 25	1.12
Oct 25	1.07
Oct 25	1.1
Oct 25	1.15
Sep 25	1.21
Sep 25	1.2
Sep 25	1.25
Sep 25	1.3
Aug 25	2.12
Aug 25	1.56
Aug 25	1.43
Aug 25	1.34
Aug 25	1.29
Jul 25	1.22
Jul 25	1.25
Jul 25	0.87
Jul 25	0.82
Jun 25	0.76
Jun 25	0.73
Jun 25	0.72
Jun 25	0.86
May 25	0.87
May 25	0.94
May 25	0.84
May 25	0.69
May 25	0.73
Apr 25	0.73
Apr 25	0.71
Apr 25	0.75
Apr 25	0.63
Mar 25	0.81
Mar 25	0.83
Mar 25	0.71
Mar 25	0.56
Feb 25	0.53
Feb 25	0.77
Feb 25	0.98
Feb 25	0.98
Jan 25	0.93
Jan 25	1.14
Jan 25	1.05
Jan 25	0.98
Jan 25	1.05
Dec 24	1.02
Dec 24	1.06
Dec 24	1.01
Dec 24	1.08
Nov 24	1.04
Nov 24	1.41
Nov 24	1.26
Nov 24	1.82
Nov 24	0.92
Oct 24	1.19

EV/EBITDA

CELU EV/EBITDA by quarter
Period	EV/EBITDA
Nov 22	7.19
Oct 22	7.56
Oct 22	7.32
Oct 22	6.69
Oct 22	6.76
Sep 22	7.46
Sep 22	8.12
Sep 22	6.82
Sep 22	7.96
Sep 22	8.96
Aug 22	9.36
Aug 22	9.16
Aug 22	9.99

Price to Book

CELU Price to Book by quarter
Period	Price to Book
Aug 25	9.59
Aug 25	8.8
Aug 25	8.2
Aug 25	7.89
Jul 25	7.49
Jul 25	7.66
Jul 25	5.34
Jul 25	5.01
Jun 25	4.68
Jun 25	4.45
Jun 25	4.43
Jun 25	5.26
May 25	5.34
May 25	5.79
May 25	5.16
May 25	4.22
May 25	2.03
Apr 25	2.05
Apr 25	1.98
Apr 25	2.09
Apr 25	1.76
Mar 25	2.25
Mar 25	2.31
Mar 25	1.97
Mar 25	1.56
Feb 25	1.48
Feb 25	2.14
Feb 25	2.72
Feb 25	2.75
Jan 25	2.61
Jan 25	3.18
Jan 25	2.93
Jan 25	2.75
Jan 25	2.93
Dec 24	2.85
Dec 24	2.96
Dec 24	2.82
Dec 24	3
Nov 24	1.6
Nov 24	2.17
Nov 24	1.93
Nov 24	2.79
Nov 24	0.99
Oct 24	1.28
Oct 24	1.72
Oct 24	1.19
Oct 24	1.25
Sep 24	1.41
Sep 24	1.41
Sep 24	1.32
Sep 24	1.33
Aug 24	1.46
Aug 24	1.49
Aug 24	1.45
Aug 24	1.33
Aug 24	1.43
Jul 24	1.95
Jul 24	1.88
Jul 24	1.84
Jul 24	1.83
Jun 24	1.95
Jun 24	1.9
Jun 24	2
Jun 24	2.02
May 24	1.94
May 24	2.15
May 24	1.87
May 24	1.84
May 24	2.05
Apr 24	1.88
Apr 24	1.89
Apr 24	2.56
Apr 24	3.31
Mar 24	3.26
Mar 24	3.23
Mar 24	3.54
Mar 24	3.85
Mar 24	2.28
Feb 24	2.89
Feb 24	2.7
Feb 24	2.66
Feb 24	3.36
Jan 24	2.14
Jan 24	1.83
Jan 24	1.35
Jan 24	1.53
Dec 23	0.37
Dec 23	0.27
Dec 23	0.28
Dec 23	0.31
Dec 23	0.34
Nov 23	0.32
Nov 23	0.31
Nov 23	0.33
Nov 23	0.35
Oct 23	0.31
Oct 23	0.35
Oct 23	0.44
Oct 23	0.32
Sep 23	0.33

No video analysis for this stock yet. Request one from our team.

News: CELU

gurufocus.com · 27 Aug 2026

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

[url="]Celularity Inc.[/url] (Nasdaq: CELU) (âCelularityâ), a longevity-focused regenerative and cellular medicine company, and [url="]MuseCell InnovationsÂ

businesswire.com · 27 Aug 2026

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

FLORHAM PARK, N.J. & SINGAPORE--(BUSINESS WIRE)--Celularity Inc. and MuseCell Innovations announce U.S. manufacturing partnership for production of Dezawa MuseCells in Florham Park, NJ facility.

globenewswire.com · 25 Aug 2026

Celularity Provides Update Regarding Nasdaq Listing Compliance

FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”) today announced that, on August 21, 2026, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC stating that, because the Company has not filed its Quarterly Report on Form 10-Q for the period ended June 30, 2026 and remains delinquent in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission.

AI Analysis

Celularity Inc.

Video analysis: CELU

News: CELU

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform

Celularity Provides Update Regarding Nasdaq Listing Compliance

Similar companies